AHR
American Healthcare REIT Inc
$
40.510
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
41.500
Open
40.400
VWAP
40.61
Vol
1.70M
Mkt Cap
6.46B
Low
39.905
Amount
68.94M
EV/EBITDA(TTM)
45.64
Total Shares
164.58M
EV
7.99B
EV/OCF(TTM)
32.93
P/S(TTM)
2.71
American Healthcare REIT, Inc. is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing, skilled nursing facilities, outpatient medical (OM) buildings and other healthcare-related facilities across the United States, the United Kingdom and the Isle of Man. It owns and operates its integrated senior health campuses and senior housing operating properties (SHOP). Its segments include integrated senior health campuses, OM, SHOP and triple-net leased properties. Its OM buildings are leased to multiple tenants under separate leases. Its integrated senior health campuses each provide a range of independent living, assisted living, memory care, skilled nursing services and ancillary businesses. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospitals. Its SHOP segment includes senior housing providing assisted living care, and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
568.99M
+5.25%
--
--
558.76M
+2.95%
--
--
550.37M
+5.07%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for American Healthcare REIT, Inc. (AHR) for FY2025, with the revenue forecasts being adjusted by -0.74% over the past three months. During the same period, the stock price has changed by 15.97%.
Revenue Estimates for FY2025
Revise Downward
-0.74%
In Past 3 Month
Stock Price
Go Up
+15.97%
In Past 3 Month
11 Analyst Rating
-1.26% Downside
Wall Street analysts forecast AHR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHR is 40.00 USD with a low forecast of 37.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
1 Hold
0 Sell
Strong Buy
-1.26% Downside
Current: 40.510
Low
37.00
Averages
40.00
High
45.00
-1.26% Downside
Current: 40.510
Low
37.00
Averages
40.00
High
45.00
Baird
Wesley Golladay
Outperform
initiated
$41
2025-07-18
Reason
Baird
Wesley Golladay
Price Target
$41
2025-07-18
initiated
Outperform
Reason
Baird analyst Wesley Golladay last night initiated coverage of American Healthcare REIT with an Outperform rating and $41 price target. The firm views the company as one of the better investments to gain exposure to the expected multi-year growth of senior managed housing. Baird sees strong organic growth from the company's senior housing and senior health campus segments amid a favorable supply and demand backdrop.
Baird
Wesley Golladay
Outperform
initiated
$41
2025-07-17
Reason
Baird
Wesley Golladay
Price Target
$41
2025-07-17
initiated
Outperform
Reason
Baird analyst Wesley Golladay initiated coverage of American Healthcare REIT with an Outperform rating and $41 price target.
Scotiabank
Nicholas Yulico
initiated
$42
2025-06-30
Reason
Scotiabank
Nicholas Yulico
Price Target
$42
2025-06-30
initiated
Reason
Scotiabank analyst Nicholas Yulico initiated coverage of American Healthcare REIT with an Outperform rating and $42 price target.
Scotiabank
Outperform
initiated
$42
2025-06-30
Reason
Scotiabank
Price Target
$42
2025-06-30
initiated
Outperform
Reason
As previously reported, Scotiabank initiated coverage of American Healthcare REIT with an Outperform rating and $42 price target. The firm like American Healthcare's high exposure to the Seniors Housing segment given its "bullish" view on the segment's growth outlook for 2025-2027, the analyst tells investors. The firm also cites the REIT's strong operating platform and secondary market exposure.
KeyBanc
Austin Wurschmidt
Overweight
maintain
$34 -> $40
2025-06-11
Reason
KeyBanc
Austin Wurschmidt
Price Target
$34 -> $40
2025-06-11
maintain
Overweight
Reason
KeyBanc analyst Austin Wurschmidt raised the firm's price target on American Healthcare REIT to $40 from $34 and keeps an Overweight rating on the shares. Following recent meetings with management and Q1 earnings, the firm views American Healthcare REIT as remaining in an attractive position to capitalize on strong long-term care fundamentals. With the summer selling season in senior housing largely underway, and management striking an upbeat tone around the core fundamentals of the business, American Healthcare REIT's operators appear poised to drive value by utilizing various levers to drive NOI, KeyBanc adds. The company should also benefit from its improving cost of capital and a growing pipeline of opportunities, which should lead to accretive, external growth investments in its RIDEA portfolio.
Truist
Buy
maintain
$32 -> $38
2025-06-09
Reason
Truist
Price Target
$32 -> $38
2025-06-09
maintain
Buy
Reason
Truist raised the firm's price target on American Healthcare REIT to $38 from $32 and keeps a Buy rating on the shares as part of a broader research note updating the firm's estimates on Healthcare REITs. Truist is projecting a 12.0% year-over-year same-store net operating income growth in 2025, consistent with the management's 9%-13% guidance range, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for American Healthcare REIT Inc (AHR.N) is 73.81, compared to its 5-year average forward P/E of 573.51. For a more detailed relative valuation and DCF analysis to assess American Healthcare REIT Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
573.51
Current PE
73.81
Overvalued PE
1754.35
Undervalued PE
-607.33
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Strongly Overvalued
5Y Average EV/EBITDA
16.35
Current EV/EBITDA
21.80
Overvalued EV/EBITDA
18.80
Undervalued EV/EBITDA
13.90
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Overvalued
5Y Average PS
1.67
Current PS
2.85
Overvalued PS
2.33
Undervalued PS
1.01
Financials
Annual
Quarterly
FY2025Q1
YoY :
+8.22%
540.60M
Total Revenue
FY2025Q1
YoY :
+45.99%
40.27M
Operating Profit
FY2025Q1
YoY :
+127.70%
-6.84M
Net Income after Tax
FY2025Q1
YoY :
-0.00%
-0.04
EPS - Diluted
FY2025Q1
YoY :
-187.79%
22.99M
Free Cash Flow
FY2025Q1
YoY :
+6.69%
19.30
Gross Profit Margin - %
FY2025Q1
3.46
FCF Margin - %
FY2025Q1
YoY :
+111.67%
-1.27
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
139.3K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
100.6K
Volume
2
6-9
Months
349.7K
Volume
3
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
2
36.3K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
139.3K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
AHR News & Events
Events Timeline
2025-08-07 (ET)
2025-08-07
16:42:39
American Healthcare REIT reports Q2 FFO 42c, consensus 40c
2025-05-08 (ET)
2025-05-08
16:46:59
American Healthcare REIT reports Q1 normalized FFO 38c , consensus 37c
2025-02-27 (ET)
2025-02-27
16:24:11
American Healthcare REIT reports Q4 normalized FFO 40c, consensus 40c
Sign Up For More Events
Sign Up For More Events
News
9.5
08-08NewsfilterPinnedAmerican Healthcare REIT, Inc. (AHR) Q2 2025 Earnings Call Transcript
9.5
08-08NASDAQ.COMPinnedAmerican Healthcare REIT (AHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
7.0
08-08SeekingAlphaAmerican Healthcare REIT raises 2025 NFFO guidance to $1.64–$1.68 amid strong NOI growth and pipeline expansion
Sign Up For More News
People Also Watch
CRGY
Crescent Energy Co
9.230
USD
+0.33%
CBZ
CBIZ Inc
63.190
USD
+2.17%
KRYS
Krystal Biotech Inc
138.660
USD
+1.88%
BKH
Black Hills Corp
60.880
USD
+0.88%
VRNA
Verona Pharma PLC
105.280
USD
-0.11%
VRRM
Verra Mobility Corp
23.490
USD
-2.41%
GBTG
Global Business Travel Group Inc
7.510
USD
+3.59%
ST
Sensata Technologies Holding PLC
29.450
USD
+0.27%
NWL
Newell Brands Inc
4.880
USD
-1.01%
PAGP
Plains GP Holdings LP
19.240
USD
-0.26%
FAQ
What is American Healthcare REIT Inc (AHR) stock price today?
The current price of AHR is 40.51 USD — it has increased 1.63 % in the last trading day.
What is American Healthcare REIT Inc (AHR)'s business?
What is the price predicton of AHR Stock?
What is American Healthcare REIT Inc (AHR)'s revenue for the last quarter?
What is American Healthcare REIT Inc (AHR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for American Healthcare REIT Inc (AHR)'s fundamentals?
How many employees does American Healthcare REIT Inc (AHR). have?